Author(s): Fosgerau K, Hoffmann T
Abstract Share this page
Abstract Peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated. Consequently, there is an increased interest in peptides in pharmaceutical research and development (R&D), and approximately 140 peptide therapeutics are currently being evaluated in clinical trials. Given that the low-hanging fruits in the form of obvious peptide targets have already been picked, it has now become necessary to explore new routes beyond traditional peptide design. Examples of such approaches are multifunctional and cell penetrating peptides, as well as peptide drug conjugates. Here, we discuss the current status, strengths, and weaknesses of peptides as medicines and the emerging new opportunities in peptide drug design and development. Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
This article was published in Drug Discov Today
and referenced in Journal of Analytical & Bioanalytical Techniques